The effect of monosodium glutamate (MSG) on blood glucose in adult rabbits as models by Oriaghan, EA et al.
 
Anthonio Research Center © 2012 10       EOriaghan et al., IJBAIR; 1(1): 10 - 18 
 
 International Journal of Basic, Applied and Innovative Research 
IJBAIR, 2012, 1(1): 10 - 18 
www.antrescentpub.com 
 
RESEARCH  PAPER 
 
THE EFFECT OF MONOSODIUM GLUTAMATE (MSG) ON BLOOD G LUCOSE IN 
ADULT RABBITS AS MODELS  
 
 
*1,2Oriaghan E.A., 1Inegbenebor U., 1Shelu O.J., 1Obhimon O., 1Idonor E.O. and 1Ekhoye I.   
1Department of Physiology, College of Medicine, Ambrose Alli University, Ekpoma, Edo State, Nigeria. 2Anthonio 
Research Center, Anthonio Services Nigeria, Ujoelen-Extension, Ekpoma. 
 
*Corresponding Author: realobobo@yahoo.com 




This study investigates the effect of monosodium glutamate on fasting blood glucose. 18 adult rabbits (1.6 ± 0.20 
Kg), procured from the animal house at the College of Medicine, Ambrose Alli University, Ekpoma, and transferred 
to the Physiology Laboratory of the same institution were used for this study. The animals were grouped into two: 
groups A (control) and B (Test B1 and Test B2). Group A received water and feed (grower’s mash) with grass 
supplementation. Group B (Test B1 and B2) received 3.33mg/ml and 6.66mg/ml of MSG respectively at libitum. At 
the end of each week, fasting blood glucose levels were determined using glucose test strips by Betachck, 
Australia, according to manufacturer’s instructions. Blood samples were also collected via venipuncture. Statistical 
analysis showed that there was no significant difference in blood glucose levels during acclimatization. However, 
B1 and B2 presented significant weekly increases in blood glucose levels especially amongst group B2 rats. This 
study suggests therefore, that MSG has the potential to nduce elevations in blood glucose level and consequently, 
diabetes mellitus in animals. 
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INTRODUCTION 
Diabetes mellitus (DM) is recognized as the world most common endocrine disorder (WHO, 1999; 2003; Ingrid and 
Mathias, 2006) and a major degenerative multi-factorial disorder (Barham and Trinder, 1972; Ogbonnia et al., 
2008). It is characterized by hyperglycemia-the primary clinical manifestation (Nodestgarrd et al., 1998), and raised 
metabolic rate (Owu et al., 2006). Associated factors include imbalance and/or abnormalities in carbohydrate, fat 
and lipoprotein metabolism (Ugochukwu et al., 2003; Scoppola et al., 2001), reactive oxygen species and oxidative 
stress (Kesavulu et al., 2002; Nayeemunnisa, 2009). 
 
Epidemiological data reveals that about 173 million people in the world are suffering from DM and there are 
postulations that this will be doubled by the year 2030 (WHO, 1999; 2003). Specifically, over 18.5 million people in 
Europe, 15.1 million in North America, 12.6 million i  Latin America, 6.6 million in USSR and 5.3 million in 
Africa suffer from DM (Barnett and O’Gara, 2003; Greenfield and Chisholm, 2004). Abnormalities in insulin 
secretion and/or cells/tissue response to insulin are reported as the major etiology (WHO, 1999; 2003). Oxidative 
stress has also been reported to play a role in the progression of the disease (Giugliono et al., 1996). 
 
The fact that food additives is a major constituent of Nigerian diets (Akpamu et al., 2011b) remains a ource of 
concern considering the controversies about their risks and benefits (Moore; 2003; Gaby; 2005; McCann et al., 
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2007). Of particular interest is the use of monosodium glutamate (MSG), which, according to Eweka and 
Om’Niabohs, (2011) is popularly known in Nigeria as Ajino-moto or White maggi. It is the sodium salt of glutamic 
acid (Pavlovic and Sarac, 2010; Egbuonu et al. 2010) reported to enhance flavour (IFTEPFSN, 1989; Filers and 
Stergink, 1991; Yamaguchi and Ninomiya, 2000), through stimulation of the orosensory receptors (Fuke and
Shimizu, 1993). There are assertions too, that MSG enhances appetite and palatability of meals (Yamaguchi, 1987; 
Rogers and Blundell, 1990). 
 
On the other hand, some studies have shown that MSGis toxic to humans and experimental animals (Ariano et al., 
2005; Belluardo et al; 1990; Egbuonu et al; 2009a,b, 2010a, b,c,d). It induces seizures, liver damage (Gonzalez-
Burgos et al; 2004; Egbuonu et al; 2009a, b; 2010a, c,d), brain d mage (Nwaopara et al., 2009; 2010a, b; 2011), 
obesity (Rogers and Blundell, 1990; Mozes et al; 2004, Egbuonu et al; 2009b, 2010b, c, d; Akpamu et al; 2011a) 
and anemia (Ashaolu et al., 2011; Akpamu et al; 2011b). This study therefore, determines the effect of chronic 
ingestion of MSG on blood glucose level using rabbits as models. 
 
MATERIALS AND METHODS  
 
Substance of Study: MSG (white maggi or Ajinomoto) was purchased in sachets of 3g each from an open market in 
Ekpoma, Edo State Nigeria. Grower’s mash used for this experiment was purchased from Bendel Feeds and Flour
Mills, Ewu, Edo State. 
 
Experimental animals: Adult rabbits (n=18) of comparable weight (1.60±0.20 kg) were procured from the animal 
house of the College of Medicine, Ambrose Alli University, Ekpoma, and transferred to the Physiology Laboratory 
of same institution. The animals were separated into three groups (A, B1 and B2) and allowed to acclimat ze for two 
weeks. Group A (n=6), served as the control while group B (B1 and B2; n=6 respectively) served as the 
experimental group. The study was conducted from July to November, 2007. However, the actual animal experiment 
lasted for a period of 10 weeks. 
 
Substance Preparation and Administration: During the acclimatization period, animals were fed ad libitum with 
grower’s mash, grass supplements and water. After acclimatization, group A (control) continued with the 
acclimatization diet, while 3.33mg/ml and 6.66mg/ml of MSG were added and mixed with the water of group B1 
and B2 respectively. 
 
To obtain 3.33mg/ml and 6.66mg/ml of MSG, 30g (10 sachets) and 60g (20 sachets) of MSG was dissolved in 
1000ml of water respectively. Administration of the MSG solution was ad libitum on daily basis for eight weeks. 
 
Sample Collection and Data Analysis: With a sterile lancet, blood samples were obtained by venipuncture at the 
animal’s ear. Fasting blood glucose was determined using glucose test strips (National Diagnostic Products, Sydney, 
Australia and marketed by Betacheck; Ref: AS BAM EVCL6) according to manufacturer’s instruction. The process 
was repeated 3 times for all the animals on weekly basis and the value recorded. 
 
Statistical Analysis: Data obtained were subjected to statistical analysis u ng SPSS software. The ANOVA test 




Table 1 shows the time representation of FBG level of rabbits fed MSG. The weekly FBG for the control varies 
between 128.00±4.47mg/dl (in the 5th week) and 123.20±3.03mg/dl (in the 10th week) MSG). In group B1 which 
received 3.33g/L of MSG, there was a sharp increase in FBG level after acclimatization, and this increas  was 
sustained in the acute state but became irregular in the chronic state in a duration dependent manner.  Similarly, the 
observed increase in FBG levels in group B2 (6.66g/L of MSG) was duration dependent until the 8th week, but in the 
9th week (3rd week of chronic period) a slight drop in FBG level was observed but rose again in the 10th week. 
 
Comparatively, there was no difference in FBG levels in the control group (group A) except for that observed in the 
5th week, which was significantly different from those of the 1st and 10th week.  However, as time progressed, FBG 
levels in group B1 became significantly different. On the contrary, group B2 presented FBG levels thatwere 
significantly-different between the periods particularly during the chronic period. 
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Table 2 shows the dosage dependent variations in FBG levels of rabbits fed MSG. During acclimatization when the 
animals were not fed MSG, FBG levels were similar as no significant changes were observed. However, during the 
acute treatment of 0mg/ml (group A), 3.33mg/ml (group B1) and 6.66mg/ml (group B2) of MSG, there was a dose 
dependent increase in the levels of FBG. Similar dose dependent changes in FBG levels were observed in the 
chronic treatment periods. In the acute and chronic treatment periods, the observed increases in FBG levels were 
significantly different (p>0.05) from those obtained for the corresponding control (group A). Also, the FBG levels 
for the 6.66mg/ml treated group were significantly different from those of 3.33mg/ml treated group. 
 
Table 1: Time course activities of varying doses of MSG on fasting blood glucose of rabbits 
 
Period Week Fasting Blood Glucose (FBG) Levels (mg/dl) 
Group A; control 
(0mg/ml MSG) 
Group B1 (3.33mg/ml 
MSG) 




1 123.60±26.1a 125.20±1.10a 125.60±2.19a 
2 126.80±1.79ab 126.80±2.28a 125.60±1.67a 
Acute 
(mg/dl) 
3 126.40±0.89ab 156.00±8.49b 168.80±6.69b 
4 127.20±1.79ab 160.40±4.16bc 175.80±7.89bc 
5 128.00±4.47b 160.00±9.70bc 178.60±5.18c 
6 125.60±0.89ab 163.20±2.68c 179.80±7.43c 
Chronic 
(mg/dl) 
7 126.00±0.00b 164.40±2.61c 183.40±10.48cd 
8 125.60±0.89ab 160.80±2.28bc 188.80±5.22de 
9 126.00±0.00ab 161.00±4.24bc 185.60±4.34de 
10 123.20±3.03a 162.40±2.19c 192.20±2.49de 




Table 2: Dose dependent activities of varying concentration of MSG on fasting blood glucose of rabbits 
 
Period Week Fasting Blood Glucose (FBG) Levels (mg/dl) 
Group A; control 
(0mg/ml MSG) 
Group B1 (3.33mg/ml 
MSG) 




1 123.60±2.61a 125.20±1.10a 125.60±2.19a 
2 126.80±1.79a 126.80±2.28a 125.60±1.67a 
Acute 
(mg/dl) 
3 126.40±0.89a 156.00±8.49b 168.80±6.69c 
4 127.20±1.79a 160.40±4.16b 175.80±7.89c 
5 128.00±4.47a 160.00±9.70b 178.60±5.18c 
6 125.60±0.89a 163.20±2.68b 179.80±7.43c 
Chronic 
(mg/dl) 
7 129.20±8.32a 164.40±2.61b 183.40±10.48c 
8 125.60±0.89a 160.80±2.28b 188.80±5.22c 
9 126.00±0.00a 161.00±4.24b 185.60±4.34c 
10 123.20±3.03a 162.40±2.19b 192.20±2.49c 








Fig 1: Line graph of the pattern of change in FBG with ingestion of varying doses of MSG 
 





The present study on the effect of MSG treatment on FBG, demonstrated that duration and dosage have significant 
effects on glycemic index. Specifically, the greatest impact on FBG was presented in group B2 at the 10th week 
(192.20±2.49mg/dl) while group B1 was at the 7th week (164.40±2.61mg/dl) as against that of the control in the 5th 
week (128.00±4.47mg/dl) which was far lower than those of B1 and B2. Although an earlier study by Go et al. 
(1973), reported that the use of MSG has no effect on blood glucose, cholesterol level and weight. It is interesting 
however, to note that more recent studies have proven its deleterious effect. In fact, there is overwhelming evidence 
on MSG toxicity (Samuels, 1999).   
 
As reported in several literatures, MSG is toxic to humans and experimental animals (Ariano et al., 2005; Belluardo 
et al; 1990; Egbuonu et al; 2009a,b; 2010a,b,c,d). It induces seizures, liver damage (Arauz-Contreras and Feria-
Velasco, 1984; Beas-Zarate et al., 1989; Gonzalez-Burgos et al; 2004; Egbuonu et al; 2009b; 2010), neurotoxic and 
brain damage (Robinzon et al., 1975; Rascher and Mestres, 1980; Hu et al., 1998; Gill et al., 2000; Nwaopara et al., 
2009; 2010a,b; 2011), obesity and hyperinsulinaemia (Bunyan et al., 1976; Iwase et al., 1998; Rogers and Blundell, 
1990; Nakagawa et al., 2000; Iwase et al., 2000; Racek et al., 2001; Dolnikoff et al., 2001; Mozes t al; 2004, 
Akpamu et al; 2011a) and anemia (Ashaolu et al., 2011; Akpamu et al; 2011b). 
Taking a cue from the obesity-inducing potentials of MSG (Rogers and Blundell, 1990; Mozes t al; 2004, Akpamu 
et al; 2011a) following its appetite and palatability enha cing potentials (Kanarek et al., 1979; Rogers and Blundell, 
1990; Bellisle et al., 1991; Colucci and Grovum, 1993; Hermanussen et al., 2006; He et al., 2008; Tsang, 2008; 
Bellisle, 2008; Carter et al., 2011) and by implication, increased energy intake, may explain the observed increases 
in FBG. 
 
On the other hand, MSG has been reported to increase the secretion of insulin (Niijima et al., 1990; Macho et al., 
2000; Mourtzakis and Graham, 2002; Chevassus et al., 2002), which in our thinking should counter the increased 
blood glucose level reported in the present study. On the contrary, certain possibilities may have accounted for this 
observed outcome. These include: 1) the fact that MSG alters the regulatory mechanisms that affects fat metabolism 
(Tsang, 2008); 2) MSG inhibits ketone secretion, resulting in an obese rat with a propensity for creating adipose 
tissue (fat) (Nakai et al., 1986; Vice et al., 2005); 3) The weakening potential of fats on insulin action (Guyton and 
Hall, 2006) and the attendant increase in FBG as shown by the results of this study. Moreover, obesity is a major 
factor for a number of co-morbidities such as noninsuli -dependent diabetes mellitus (Haslam and James, 2005). 
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Another line of thought is deducible from the neurotoxic and brain damaging effects of MSG (Robinzon et al., 1975; 
Rascher and Mestres, 1980; Hu et al., 1998; Gill et al., 2000; Nwaopara et al., 2009; 2010a, b; 2011). Recall the 
involvement of the hypothalamus in the regulation and ction of insulin (Guyton and Hall, 2006); a horm ne that 
metabolizes glucose. Since the brain cells are damaged by MSG, they may be dormant to blood glucose lev l and or 
the feedback regulatory mechanism may not function to regulate insulin secretion. Backing up these assumptions is 
the report of Ashaolu et al., (2011).  
 
Furthermore, our findings are in agreement with those reported by Cameron et al., (1976), Komeda et al. (1980) and 
Nagata et al. (2006) that MSG has the potentials to trigger diabetes mellitus. Recall once more, that di betes mellitus 
is a multi-factorial degenerative disorder (Barham nd Trinder, 1972; Ogbonnia et al., 2008). In the same vein, MSG 
induces a number of organ-damage (Moses and Sefcikova, 2004; Farombi, 2006; Eweka, 2007; Vinodini et al., 
2010) and has immune compromising potentials (Ashaolu et al., (2011). Thus, indiscriminate MSG ingestion and the 
incidence of diabetes mellitus are two inseparable ph nomena. It is our opinion therefore, that the there is an urgent 
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